BiotechTube
Home/DalCor Pharmaceuticals/Fouzia Laghrissi-Thode, M.D.
FL

Fouzia Laghrissi-Thode, M.D.

Chief Executive Officer

DalCor Pharmaceuticals

Therapeutic Areas

Cardiovascular

DalCor Pharmaceuticals Pipeline

DrugIndicationPhase
dalcetrapibReduction of recurrent myocardial infarction in post-acute coronary syndrome (ACS) patients with ADCY9 AA genotypePhase 3

Leadership Team at DalCor Pharmaceuticals

MD
Michael Dixon, C.P.A., C.A.
Chief Financial Officer
View full DalCor Pharmaceuticals profile